StockClub

SNDX

SNDXSyndax Pharmaceuticals, Inc.$ --
Syndax Pharmaceuticals, Inc.

Syndax Pharmaceuticals, Inc.

SNDX

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 03/31/2026FY2026 Q1
Revenue
65M USD
YoY +223.6%
Operating Income
-34M USD
YoY +59.2%
Net Income
-43M USD
YoY +49.7%
EPS
-0.49$
YoY +50.5%

Revenue

$64.9M
FY2024 Q2$3.5M
$3.5M
Q2
FY2024 Q3$16M
$16M
Q3
FY2024 Q4$23.7M
$23.7M
Q4
FY2025 Q1$20M
$20M
Q1
FY2025 Q2$58M
$58M
Q2
FY2025 Q3$103.9M
$103.9M
Q3
FY2025 Q4$172.4M
$172.4M
Q4
FY2026 Q1$64.9M
$64.9M
Q1
Actual
+$44.8M (+223.6%)

Net Income

$-42.7M
FY2024 Q2$-140.5M
$-140.5M
Q2
FY2024 Q3$-224.6M
$-224.6M
Q3
FY2024 Q4$-318.8M
$-318.8M
Q4
FY2025 Q1$-84.8M
$-84.8M
Q1
FY2025 Q2$-156.7M
$-156.7M
Q2
FY2025 Q3$-217.4M
$-217.4M
Q3
FY2025 Q4$-285.4M
$-285.4M
Q4
FY2026 Q1$-42.7M
$-42.7M
Q1
Actual
+$42.2M (+49.7%)

Surprise History

Actual RevenueAnalyst Estimate
FY2020BEAT
Actual:$1.5M
Est:$1.5M
FY2020BEAT
$1.5M
FY2021BEAT
Actual:$139.7M
Est:$19.1M
FY2021BEAT
$139.7M
FY2022MISS
Actual:$0
Est:$375,000
FY2022MISS
$0
FY2023MISS
Actual:$0
Est:$3.5M
FY2023MISS
$0
FY2024MISS
Actual:$23.7M
Est:$48.3M
FY2024MISS
$23.7M
FY2025BEAT
Actual:$172.4M
Est:$168.1M
FY2025BEAT
$172.4M

Analyst Estimates